Call for Nominees

Paediatric HIV Advisory Panel

January 2024

Table of content

Call for Nominees................................................................................. 3

1....... Why a Paediatric HIV Advisory Panel?........................................ 4

1.1..... About the Paediatric HIV Advisory Panel............................................................ 4

1.2..... Who can join the Paediatric HIV advisory panel?............................................... 5

1.3..... Selection process............................................................................................... 5

1.4..... Interested? How to apply?................................................................................. 6

2....... Annex 1: Terms of Reference for the Paediatric HIV Advisory Panel............................................................................................ 7

2.1..... Introduction...................................................................................................... 7

2.2..... About Aidsfonds - Soa Aids Nederland............................................................... 7

2.3..... About Paediatric HIV......................................................................................... 7

2.4..... Aidsfonds Paediatric HIV programme................................................................ 9

2.5..... About the Paediatric HIV Advisory panel.......................................................... 10

2.6..... Who can join the Paediatric HIV Advisory panel?............................................. 11

2.7..... General regulations of the Paediatric HIV Advisory Panel................................. 11

Call for Nominees

Are you a passionate professional with experience with community-based Paediatric HIV, or do you have lived experiences? Do you wish to join five members who share the mission to contribute to a world free from AIDS and where children and adolescents living with HIV have a healthy future? We are looking for 2 new members to join our Paediatric HIV Advisory Panel.

The panel was established in 2023 to advice Aidsfonds on paediatric HIV strategies, models, theory of change and funding mechanisms and to co-decide on funding e.g., for Aidsfonds calls for proposals for Paediatric HIV programmes. The panel currently consists of paediatric experts, experienced in working with community-based models, (young) mothers with children living with HIV and/or having lived experiences as well as health care professionals/community health workers from East Africa, Southern Africa and Indonesia. We are looking for two new members preferably from South Africa and/or Cameroon, Nigeria with a strong experience in governance and implementation of paediatric HIV programmes.

1                Why a Paediatric HIV Advisory Panel?

Aidsfonds – Soa Aids Nederland, based in Amsterdam, is a Dutch organisation that also works internationally. At Aidsfonds - Soa Aids Nederland, we strive for a world where there are no longer any deaths from AIDS and where people enjoy good sexual health. A world in which everyone can love freely and without fear. We do this by working together with the people who are hit hardest by HIV, STIs, discrimination and exclusion. We strengthen their voices and support them with access to information, knowledge, and funding. For all that is love. Our three dream goals are: no more deaths from AIDS and no new HIV infections; sexual health and rights for all; and a cure available for everyone living with HIV.  For more information see: www.aidsfonds.org.

To have the most impact towards our strategic dream goals, Aidsfonds - Soa Aids Nederland involves communities through co-decision making on all organizational levels. For Aidsfonds - Soa Aids Nederland co-decision making, with meaningful involvement of people living with HIV, community activists and community experts and other members, directly contributes to innovative solutions for some of the most complex challenges facing the STI-, HIV and AIDS response. 

1.1         About the Paediatric HIV Advisory Panel 

In September 2023, we announced our inaugural Paediatric HIV Advisory Panel (PHAP) for the years 2023-2024. The panel's primary role is to advise Aidsfonds on paediatric HIV strategies, models, and funding mechanisms, as well as to collaborate in the decision-making process for funding, including Aidsfonds’ calls for proposals aiming to expanding the Kids to Care model to Zambia, Malawi, Tanzania, and Indonesia/West Papua under the paediatric HIV programs. 

Five members have joined our first Paediatric HIV Advisory Panel bringing a wealth of experience in community-based paediatric HIV, capacity building of health workers on paediatric HIV, lived experiences as mothers living with HIV, strengthening caregivers' literacy on paediatric HIV treatment, and advocacy for the rights of children living with HIV.

The Paediatric HIV Advisory Panel members are committed to representing the voices of their communities by ensuring that the perspectives and needs of those they serve are genuinely considered in policy and decision-making processes. Together, they will work towards addressing issues related to the rights of children and young women living with HIV, striving to provide them with equal access to affordable, timely, acceptable, and quality HIV care services. The panel members come from different countries including Indonesia, Kenya, Namibia, Uganda, and Zimbabwe.

Our commitment to community-driven decision-making lies at the heart of our 2022-2025 strategy. We passionately believe that empowering the communities most affected is the key to impactful change. Community members possess exceptional insights into what works and what does not, thanks to their deep understanding of the intersections between issues and solutions. For this reason, we are looking to expand our PHAP to welcome two new members on board. 

In 2023 the Paediatric HIV Advisory Panel (PHAP) was involved in the selection of four new country programmes, the development of our paediatric HIV Theory of Change model and the evaluation of the first six months of the PHAP. In 2024 the members joint an introduction meeting for all paediatric partner organisations of Aidsfonds. Furthermore, they will focus on the selection of a new partner in Cameroon, the adoption of the new Theory of Change, advise towards the pilot projects and be involved in the Paediatric HIV priorities as part of Aidsfonds new strategy (2026-2029).

For more details, please consult the Terms of Reference in Annex 1 and the Planning for 2024 in Annex 2.

1.2         Who can join the Paediatric HIV Advisory panel?

The Paediatric HIV Advisory Panel consists of 5 representatives from East Africa, Southern Africa and/or Nigeria or Indonesia. We are looking for an additional two new members preferably from South Africa and/or Cameroon, Nigeria with a strong experience in governance and implementation of paediatric HIV programmes. In general, the new member suits the below criteria:

Selection criteria for panel members:

l Three to five years’ practical experience with community-based interventions for children living with HIV, pregnant and lactating women living with HIV/AIDS.

l Expertise in paediatric and youth HIV responses in community clinics, health facilities, government and or private hospitals, in East Africa, Southern Africa and/or Cameroon, Nigeria or Indonesia.

l Experience in reviewing proposals from consortia and/or complex project applications and/or can provide relevant advice for strategic direction programmes on paediatric AIDS country programmes and Aidsfonds paediatric HIV programme in general.

l Demonstrated experience in governance structures, policies, and procedures within the healthcare or public health sector.

l Ability to contribute to the development and enhancement of governance frameworks that align with international public health standards, differentiated service delivery, and organizational objectives.

l Familiar with paediatric HIV strategies, funding mechanisms and evaluations, and/or mothers of children living with HIV because of their experiences with paediatric HIV programmes. Aidsfonds values lived experiences of community members for whom these paediatric community-based HIV services are designed for.

As a paediatric HIV advisory panel member, you are willing to sign and uphold Aidsfonds’ policy on confidentiality, as well as Aidsfonds integrity policies and conflict of interest policies. In addition, all members are computer literate, have access to computer and internet and are able to attend (virtual) meetings with the panel. Members will receive a stipend, consisting of costs for (virtual) meetings and other relevant expenses covered by a fixed lump-sum per year.

The selection of members will be based on the above criteria and on the additional criteria:

l Members speak and understand English fluently

l Members participate in the panel based on individual merit and expertise, not as representative of any organisation

l Members are not employees or board/committee members of Aidsfonds current paediatric HIV partner organisations

l You are available from March 2024 onwards

The paediatric HIV advisory panel member is expected to participate in all meetings including evaluation meetings. Therefore, the estimated time investment is expected to be between 7 to 9 days per year.

1.3         Selection process 

The process for the selection of the members of the Advisory Panel includes the following steps: 

l Nominations will be reviewed based on the criteria and comparatively scored by a subcommittee set by the Paediatric HIV team of Aidsfonds. Thereafter shortlisted candidates are invited for a first round of interviews and a final selection is made. 

l The Paediatric HIV team of Aidsfonds appoints the Paediatric HIV Advisory Panel members, based on their motivation letter and curriculum vitae, as well as interviews.

l The chair and vice chair will be nominated by majority vote by the Paediatric HIV Advisory Panel at the beginning of each two-year term. PHAP members have already voted for the chair and vice chair for this period; More information about the roles and responsibilities of chair and vice-chair can be found in annex 2 of the Terms of Reference.

1.4         Interested? How to apply? 

Applications can be submitted before 29th of February 2024 through the HR portal of Aidsfonds. The following information is required:

l Motivation letter including how you fulfil the required profile (maximum of 1 page). In your motivation letter you explain why you are interested to join the Paediatric HIV Advisory Panel, and what you can bring to the panel.

l CV or resume demonstrating relevant experience, expertise and a record of accomplishment including similar advisory work undertaken (maximum of 4 pages).

The selection process will take place in March 2024.

In case of questions or more details: please contact Carmen Roebersen at: croebersen@aidsfonds.nl   

2    Annex 1: Terms of Reference for the Paediatric HIV Advisory Panel

2.1         Introduction

To have the most impact towards our strategic dream goals, Aidsfonds - Soa Aids Nederland involves communities through co-decision making on all organizational levels. Aidsfonds is inviting expert members for the paediatric HIV Advisory Panel, as well as health care professionals/community health workers and community members, being (young) mothers with children living with HIV. The panel is established to advice Aidsfonds on paediatric HIV strategies, models, and funding mechanisms and to co-decide on funding e.g., for Aidsfonds calls for proposals for Paediatric HIV programmes.

For Aidsfonds - Soa Aids Nederland co-decision making with meaningful involvement of people living with HIV, community activists and community experts and other members, directly contributes to innovative solutions for some of the most complex challenges facing the STI-, HIV and AIDS response.  

2.2         About Aidsfonds - Soa Aids Nederland 

Aidsfonds – Soa Aids Nederland, based in Amsterdam, is a Dutch organisation that also works internationally. At Aidsfonds - Soa Aids Nederland, we strive for a world where there are no longer any deaths from AIDS and where people enjoy good sexual health. A world in which everyone can love freely and without fear. We do this by working together with the people who are hit hardest by HIV, STIs, discrimination and exclusion. We strengthen their voices and support them with access to information, knowledge, and funding. For all that is love. Our three dream goals are: no more deaths from AIDS and no new HIV infections; sexual health and rights for all; and a cure available for everyone living with HIV.

Aidsfonds Soa aids Nederland works in three roles: As an advocate, we raise our voice and join others to move governments, scientists, and funders to improve the rights and health of communities and scale up innovative solutions; As an expert, we work evidence-based and we built on the knowledge and experiences of communities, health professionals and the public to increase their knowledge and agency; As an involved fundraiser & funder, we support inclusive HIV cure research and innovative community solutions. For more information see: www.aidsfonds.org/.

2.3         About Paediatric HIV 

Children (0-14) who acquired HIV have an elevated risk of morbidity and mortality. Half of infants with HIV infection will die before their second birthday if they do not receive treatment. This is unexceptionally high. According to UNAIDS 2023, an estimated 1.5 million children were worldwide living with HIV in 2022. In the same year, 130,000 children newly acquired HIV and 84,000 children died of AIDS. Children account for 13% of all AIDS-related deaths, even though only 4% of the total number of people living with HIV are children[1]. Many of these children are living in Aidsfonds’ focus countries (see Figure 1).

Despite the Sustainable Development Goal target to end AIDS as a public health threat by 2030 and the 95-95-95 targets[2] progress is stagnating. Progress on paediatric HIV remains behind because of several reasons such as limited funding for paediatric HIV interventions[3]. limited commitment of countries, and the failure to find and test children and their mothers to put them on treatment. An exceptionally high number of children living with HIV, over 40%, are not aware of their HIV status. Consequently, this contributes to a treatment gap. Adding to that is that it remains challenging to eliminate vertical transmission. The rate of transmission of HIV from a mother living with HIV to her child during pregnancy, labour, delivery or breastfeeding ranges from 15% to 45%. There are multiple gaps in preventing vertical transmission, namely, mothers not receiving antiretroviral therapy, mothers dropping out of care, or mothers getting infected during pregnancy or the breastfeeding period.

2.4         Aidsfonds Paediatric HIV programme

The Aidsfonds’ paediatric HIV programme (2015 – 2025) is based on an unwavering commitment to end AIDS-related deaths and reduce new HIV infections in children. Currently the programmes work in five countries[4] and seeks to expand to Malawi, Tanzania, Zambia and Indonesia/West Papua. We strive to eliminate vertical transmission[5] and ensuring all children living with HIV and their mothers should be able to live healthy and full lives.

2.4.1      The paediatric HIV programme:

l is impactful, between 2018 and 2021 a total of 336,237 children and mothers have been tested with HIV and 4,000 children and mothers were put on life saving anti-retroviral treatment.

l provides funding that is longer-term, flexible and supports community-based organisations directly. The paediatric HIV programme is funded by multiple donors, including ViiV Healthcare and private donations.

l is evidence-based, in 2015 we piloted community-based responses to paediatric HIV in Uganda. Based on the positive results and lessons we scaled the pilot to Mozambique, Nigeria, Zimbabwe and South Africa. Since then, we have developed the evidence-based Kids to Care model.

The Kids to Care model, is a community based approach, that effectively reduced new HIV infections and AIDS-related deaths by ensuring we find, test, and treat children and mothers living with HIV and support them to stay in care. The Kids to Care model:

l is community-based, rooted in community knowledge and comprises of four main objectives that mutually reinforce each other: (1) community-based HIV programmes linked to health facilities, (2) advocacy for improved paediatric HIV services, (3) build a knowledge base and (4) strong partnerships for cooperation, exchange and fundraising.

l puts communities at the centre because communities know their children. Community health workers are crucial in each stage of HIV care to ensure children get the care they need. Communities are involved through co-decision making to advice on Aidsfonds’ paediatric HIV strategies, models, and funding mechanisms and to co-decide on funding.

l is contextualized and sensitive to country specific needs, obstacles and challenges of children. Together with governments, partner organisations and the paediatric HIV advisory panel we work towards sustainable country specific solutions.

l contributes to Aidsfonds’ Strategy 2022-2025 'For All that is Love'.

2.4.2      Our four objectives:

1. Aidsfonds together with partner organisations strengthens existing community-based responses and their collaboration with health facilities in paediatric HIV to find and support infants and children living with HIV, empower pregnant and lactating (young) women living with HIV and train health care workers, using the Kids to Care model as a best practice for paediatric HIV interventions.
2. Aidsfonds and partner organisations advocate for governments and funders to invest in effective community based interventions and to provide access to and availability of HIV treatment and care including pDTG, EID. And for the integration of adolescent HIV-services into national SRHR and maternal health policies and services, including PMTCT, family-planning[6].
3. Building knowledge base through research and data collection to generate evidence and to influence future programming, policies and funding at national, regional, and international levels of other organisations, donors, and governments.
4.  Accelerate results by building strategic partnerships with national, international and global organisations including funders to amplify results and foster mutual learning (linking and learning) while securing vital resources to fuel community-driven solutions for for paediatric HIV. Notably, Aidsfonds works with GNP+, Global Alliance to End Aids in children and EGPAF, PATA, ViiV Health.

Figure 2: The Kids to Care model

2.5         About the Paediatric HIV Advisory panel

Aidsfonds believes that a Paediatric HIV Advisory Panel serves as a voice for the communities, and that the panel’s expertise helps to create and fund more impactful projects. As mentioned above the panel has several roles:

Provide funding advice to Aidsfonds during the selection processes of proposals: In August 2023, a call for proposals is launched. EUR 1.600,000 is available to expand Aidsfonds’ Kids to Care model to Zambia, Malawi, Tanzania and Indonesia. Aidsfonds invites community-based organisations and non-governmental organisations, based in these four countries to apply through Aidsfonds’ online grant-making portal. The paediatric HIV advisory panel will discuss eligible proposals, provide feedback to the reviewed proposals and advise Aidsfonds on the funding decision. Consequently, selected applicants are invited for the due diligence process in preparation of a contract for the period 2024-2025. The due diligence and contract management will be handled by Aidsfonds.

Formulation of advice towards paediatric HIV strategies and models, funding mechanisms and evaluation of the Paediatric HIV programme. The panel will be invited by Aidsfonds paediatric team when paediatric HIV strategies and models are to be reviewed or evaluated, and to provide funding advice on e.g., for Aidsfonds calls for proposals for Paediatric HIV programmes.

Internal evaluation of work of the panel. When advisory processes and proposal selection processes are completed, there is a lot to learn from the process itself. The panel will engage on reflection and evaluation of the processes, to sharpen shared decision making and the processes to facilitate this. Lessons learnt will be documented and taken into consideration when formulating new advisory processes and for example adjusting panel governance structures.

The estimated time investment is expected to be between 5 to 7 days per year. More information about the regulations of the Paediatric HIV advisory panel can be found in section 7.

2.6         Who can join the Paediatric HIV Advisory panel?

The Paediatrics HIV advisory panel consists of 5-7 representatives from East Africa, Southern Africa and/or Nigeria or Indonesia. Including 3 Paediatric HIV experts, 2 health care professionals/community health workers, 2 (young) mothers of children living with HIV.

2.6.1      Criteria for panel members: 

l Proven expertise with implementation of the Kids to Care model or similar community-based models

l Three to five years’ experience with community-based interventions for children living with HIV, pregnant and lactating women living with HIV/AIDS.

l Expertise in paediatric HIV responses in community clinics, health facilities, government and or private hospitals, in East Africa, Southern Africa and/or Nigeria or Indonesia

l Experience in reviewing proposals from consortia and/or complex project applications and/or can provide relevant advice for strategic direction programmes on paediatric AIDS country programmes and Aidsfonds paediatric HIV programme in general

l Are familiar with Paediatric HIV strategies, funding mechanisms and evaluations, and/or

Mothers of children living with HIV because of their experiences with paediatric HIV programmes. Aidsfonds values lived experiences of community members for whom these paediatric community-based HIV services are designed for

As a paediatric HIV panel member you are willing to sign and uphold Aidsfonds’ policy on confidentiality, as well as Aidsfonds integrity policies and conflict of interest policies. In addition, members are computer literate, have access to computer and internet, and able to attend (virtual) meetings with the panel.

The selection of members will be based on the above criteria and on the additional three criteria:

l Members speak and understand English fluently.

l Members participate in the panel based on individual merit and expertise, not as representative of any organisation.

l Members are not employees or board/committee members of Aidsfonds current paediatric HIV partner organisations.

l You are available from September 2023 onwards.

2.7         General regulations of the Paediatric HIV Advisory Panel

As a Paediatric HIV expert, your knowledge, experience, and recommendations are highly valuable for the paediatrics HIV team at Aidsfonds. The Paediatric HIV Advisory Panel is considered as the primary vehicle through which the community shares local knowledge and lived experience, ensuring the work is guided by a robust understanding of the community and by relevant data that can lead to more effective projects. Below more information can be found on the establishment of the panel and its operating principles.

2.7.1      Time investment and Meetings 

It is estimated that the membership of the Paediatric HIV Advisory Panel will take about five to seven days per year on average. The meetings are aligned with ongoing processes of strategy evaluation or development, funding allocations and other key processes within the Paediatric HIV team of Aidsfonds Soa Aids Nederland. 

The quorum for meetings of the Paediatric HIV Advisory Panel in which advice is formulated, is 5 members. The members are not entitled to appoint delegates to attend meetings, or otherwise carry out their functions as members of the Paediatric HIV Advisory Panel in their place. 

The Paediatric HIV Advisory Panel can meet on their own initiative or by a request from Aidsfonds - Soa Aids Nederland in order to address specific issues. For specific purposes, members of the Paediatric HIV Advisory Panel can be invited to the Paediatric HIV team meetings to provide input on topics relevant to the activities of the team. 

Meetings will be complemented by e-mail communication and teleconferencing in preparation of official meetings if necessary.

2.7.2      Chair, vice-chair, and secretary 

During the first official meeting the Paediatric HIV Advisory Panel selects its chair and vice-chair for a period of two years. Each two-year period the (re)election of these positions takes place during the first annual meeting. The chair and the vice-chair will together identify and organise any need for support e.g., with understanding previous processes, understanding budgets/other background documents.

Aidsfonds Paediatric HIV project lead will take the position as secretary of the Paediatric HIV Advisory Panel to ensure good preparation of meetings and minute taking, availability of all relevant information and a connection with the organisation. Logistics and the agenda of Paediatric HIV Advisory Panel meetings are determined by the chair and the Paediatric HIV project lead with the input from all involved parties. The Paediatric HIV project lead does not count as a member in a meeting where advice is formulated.

All meetings will be documented, and the minutes will be shared by the chair with the Paediatric HIV team of Aidsfonds Soa Aids Nederland. 

2.7.3      Advice 

Advice from the Advisory Panel will be duly formulated in writing and is directly given to the Paediatric HIV project lead of Aidsfonds Soa Aids Nederland. The advice is formulated and given based on consent with any minority voice included. If the Advisory Panel is unable to come to a unanimous advice during meetings, by exception voting can be used, with majority vote of minimum 60% (3 out of 5 or 4 out of 7 members). In that case, the dilemma underlying the vote is presented in the advice with all considerations for and against.

2.7.4      Procedures for feedback to advice 

Paediatric HIV project lead of Aidsfonds Soa Aids Netherlands commits to a full written response on the advice received, how it is applied within the Paediatric HIV team and what the (long term) effects of the advice are. One of the key principles is the separation of the advice from the final decision-making process which is the sole responsibility of Paediatric HIV team of Aidsfonds - Soa Aids Nederland.

2.7.5      Code of conduct 

Paediatric HIV Advisory Panel members adhere to their own code of conduct, ensure a safe and welcoming environment and report any conflict of interest or other conflicts to the project lead. 

2.7.6      Membership terms 

The term of membership on the Paediatric HIV Advisory Panel is two years. For the sake of effectiveness and continuity, at least one third of the members will continue to serve a second term. Diversity of members should be guaranteed during the rotation procedure (e.g., country, scientists, community health experts).

Upon any vacant membership positions, a new call for nominees will be published by the Paediatric HIV team of Aidsfonds - Soa Aids Nederland. The Advisory Panel recruits and nominates members according to the published profile. The Paediatric HIV team appoints and announces the nominated members for a period of two years.

Paediatric HIV Advisory Panel members are asked to read the Conflict-of-interest policy of Aidsfonds - Soa aids Nederland and sign the conflict-of-interest declaration after declaring any past, current and near future involvement in organisations, businesses, and research project. The Advisory Panel commits to an annual internal evaluation and reflection of the panel's operations including advice on the way forward.

2.7.7      Stipend

Paediatric HIV Advisory Panel members are not remunerated for their participation on the Paediatric HIV Advisory Panel, but costs for (virtual) meetings and other relevant expenses are covered by a fixed lump-sum per year. Costs for face-to-face meetings (transport, accommodation, catering, venue) will be covered by Aidsfonds - Soa Aids Nederland. 

2.7.8      Conflict of interest 

A conflict of interest is defined as a situation in which someone cannot make a fair decision because they will be affected by the result. Paediatric HIV Advisory Panel members are required to declare any personal, private, or commercial interests that might conflict with the interests of Aidsfonds – Soa Aids Nederland. Panel members with a conflict of interest must be absent from any discussion of topics in which they have such an interest. Procedures for conflict of interest are described in the Aidsfonds Soa Aids Nederland Conflict of Interest policy.  

Because of the Paediatric HIV Advisory Panel mission, members of the panel are excluded from applying for Aidsfonds - Soa Aids Nederland funding.

2.7.9       Transparency 

The names of Paediatric HIV Advisory Panel members might be made available to the public and published on the Aidsfonds – Soa Aids Nederland website. 

2.7.10  Confidentiality 

Members of the Paediatric HIV Advisory Panel keep all information concerning Aidsfonds Soa Aids Nederland, its’ staff and board members confidential. In case of major concerns there is the possibility to apply the Aidsfonds – Soa Aids Nederland whistle-blower policy.

2.7.11  Recruitment of members 

The call for members for the Paediatric HIV Advisory Panel will be shared through the usual online (media) platforms of Aidsfonds – Soa Aids Nederland, the website, and professional networks of Aidsfonds – Soa Aids Nederland. The call will be open for 20 days. Panel members are appointed from a pool of applicants following the above-mentioned profiles and selection criteria below. Distribution of any consecutive calls for new members also involve Advisory Panel members.

2.7.12  Selection process 

The process for the selection of the members of the Advisory Panel includes the following steps: 

1. Nominations will be reviewed based on the criteria below and comparatively scored by a subcommittee set by the Paediatric HIV team of Aidsfonds – Soa Aids Nederland. Thereafter shortlisted candidates are invited for a first round of interviews and a final selection is made. 
2. The Paediatric HIV team of Aidsfonds – Soa Aids Nederland appoints the Advisory Panel members, based on their motivation letter and curriculum vitae, as well as initial interviews.
3. The chair and vice chair will be nominated by majority vote by the Advisory Panel at the beginning of each two-year governing term. A specific section for the roles and responsibilities of chair and vice-chair is included in the Advisory Panel Terms of Reference.

2.7.13  Reappointment 

Reappointment of members shall require nomination by the chair and submission of recommendations from the Paediatric HIV Advisory Panel for appointment by the Paediatric HIV team, as per the selection process. The balance of membership in respect of Paediatric HIV Advisory Panel objectives shall be considered when making any reappointments.

2.7.14  Procedures for membership termination 

The membership to the Paediatric HIV Advisory Panel may be terminated by the Paediatric HIV team for any of the following reasons: 

1. The member becomes incapable by reason of illness or injury of managing and administering their own affairs. 
2. The member resigns from the Advisory Panel by notice to the Chairs of the Advisory Council. 
3. The member is absent without notification to chair or vice-chair from an in-person meeting of the Advisory Panel. 
4. The member is absent for two consecutive meetings, without notification to the chair or 50% of all meetings planned during a period of one year.
5. The member takes up employment with Aidsfonds – Soa Aids Nederland.
6. The Advisory Panel recommends removal for failure to perform as a member or due to a conflict of interest that is antagonistic to the interests of the Paediatric HIV team and/or the full organisation, or to a violation of the confidentiality rules.